ANRO Alto Neuroscience, Inc.
$23.19▲ +4.88%
Healthcare
Other
After hours
$23.19▲ +0.00%
Oct 27, 5:05 PM ET
Volume 469.2K
Avg Volume (10D) 777.5K
Key Metrics & Fundamentals
Market Cap
$910.02M
P/E Ratio
–
Div Yield
0.00%
52W Range
10.20 - 37.48
% vs 50 MA
-19.90%
% vs 200 MA
-4.02%
RSI-14
42.0
MACD Histogram
+0.2400
Beta (1Y vs SPY)
1.70
Free Cash Flow
-$19.76M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$26.96M
COGS
–
Operating Exp
$29.13M
Operating Income
-$29.13M
EBIT
-$29.13M
Pretax Income
-$27.64M
Net Income
-$27.64M
EPS (Diluted)
-0.65
Price & Volume History
Loading chart…
Recent News
HC Wainwright Adjusts Alto Neuroscience Price Target to $60 From $55, Maintains Buy Rating
MT Newswires · Oct 19, 2026 9:33 AM ET
Here's Why You Should Add ANRO Stock to Your Portfolio Now
Zacks · Oct 14, 2026 8:59 AM ET
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Zacks · Oct 13, 2026 8:40 AM ET
Alto Neuroscience Insider Sold Shares Worth $3,567,247, According to a Recent SEC Filing
MT Newswires · Oct 2, 2026 3:48 AM ET
Alto Neuroscience Announces Participation in Upcoming Investor Conferences
Business Wire · Sep 9, 2026 8:03 AM ET
Alto Neuroscience Promotes Nick Smith to President and CFO
MT Newswires · Aug 27, 2026 5:12 PM ET
Alto Neuroscience Promotes Nick Smith to President and Chief Financial Officer
Business Wire · Aug 27, 2026 4:05 PM ET
Alto Neuroscience (ANRO) Reports Another Quarterly Loss, Is The Stock Already Overvalued?
Simply Wall St. · Aug 16, 2026 4:07 PM ET
Are Alto Neuroscience’s (ANRO) Rising Losses Funding a Stronger Depression Pipeline or Diluting Discipline?
Simply Wall St. · Aug 16, 2026 4:08 AM ET
Alto Neuroscience (ANRO) Stock Looks Stretched On Expanded ALTO 207 Plans
Simply Wall St. · Aug 15, 2026 11:16 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ANRO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.